Huons
Scope
Date
~
-
Bio & PharmaHuons receives A grade in ESG evaluation
South Korea’s Huons Co. said on Tuesday that it received an A (excellent) grade in the 2024 ESG evaluation recently released by the Korea Inst...
Oct 31, 2024 (Gmt+09:00)
-
Bio & PharmaHuons’ overseas market expansion leads to record-high sales
South Korea's Huons Group is continuing its record-breaking performance while expanding its influence in the global market.According to Huons Group ...
Jul 25, 2023 (Gmt+09:00)
-
Bio & PharmaHuons’ 2% lidocaine gets approval from FDA
South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...
Jun 19, 2023 (Gmt+09:00)
-
Bio & PharmaHuons sees tripling of lidocaine vial output in 3 years
South Korea’s Huons Co., an anesthetics vial producer, aims to triple its lidocaine output from 2026, targeting the US market, where it fills ...
May 09, 2023 (Gmt+09:00)
-
Bio & PharmaS.Korea's Huons gets approval to supply anesthetics to Canada
Huons Co., a South Korean pharmaceutical company, has announced plans to expand its presence in the North American market by offering two anesthetic...
Feb 28, 2023 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand
